PAGGIARO, PIERLUIGI
 Distribuzione geografica
Continente #
EU - Europa 871
Totale 871
Nazione #
IT - Italia 871
Totale 871
Città #
Genova 594
Rapallo 151
Genoa 123
Bordighera 3
Totale 871
Nome #
null 200
Why use long acting bronchodilators in chronic obstructive lung diseases? An extensive review on formoterol and salmeterol 111
Which factors affect the choice of the inhaler in chronic obstructive respiratory diseases? 107
Randomized controlled trials and real life studies. Approaches and methodologies: A clinical point of view 99
The ARGA study with general practitioners: Impact of medical education on asthma/rhinitis management 98
Impact of asthma and comorbid allergic rhinitis on quality of life and control in patients of italian general practitioners 97
Economic impact of mepolizumab in uncontrolled severe eosinophilic asthma, in real life 47
Mild/Moderate Asthma Network in Italy (MANI): a long-term observational study 33
Differences in the efficacy and safety among inhaled corticosteroids (ICS)/long-acting beta2-agonists (LABA) combinations in the treatment of chronic obstructive pulmonary disease (COPD): Role of ICS 29
Biologics in Severe Eosinophilic Asthma: Three-Year Follow-Up in a SANI Single Center 24
Aspergillus-related diseases in a cohort of patients with severe asthma: A SANI single-center report 18
Oral CorticoSteroid sparing with biologics in severe asthma: A remark of the Severe Asthma Network in Italy (SANI) 17
Long-Term Efficacy of Mepolizumab at 3 Years in Patients with Severe Asthma: Comparison with Clinical Trials and Super Responders 13
Severe Asthma Network Italy Definition of Clinical Remission in Severe Asthma: A Delphi Consensus 6
Totale 899
Categoria #
all - tutte 3.034
article - articoli 3.034
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.068


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020296 13 4 11 15 24 27 35 23 89 31 18 6
2020/2021127 8 3 53 5 3 9 7 5 8 7 9 10
2021/2022109 6 4 5 10 5 14 1 21 11 8 5 19
2022/2023170 8 14 3 10 26 28 0 10 37 0 31 3
2023/2024110 5 14 0 13 1 31 7 6 8 3 7 15
2024/20251 1 0 0 0 0 0 0 0 0 0 0 0
Totale 899